Perrigo Company PLC (NYSE:PRGO) CFO Ronald Winowiecki sold 826 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $48.03, for a total transaction of $39,672.78. Following the sale, the chief financial officer now directly owns 6,952 shares in the company, valued at $333,904.56. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

NYSE:PRGO traded down $1.43 during trading hours on Friday, hitting $46.34. 1,007,879 shares of the stock traded hands, compared to its average volume of 1,325,682. The firm has a 50 day moving average price of $50.38 and a 200 day moving average price of $48.47. The company has a current ratio of 1.92, a quick ratio of 1.39 and a debt-to-equity ratio of 0.54. Perrigo Company PLC has a fifty-two week low of $36.28 and a fifty-two week high of $78.90. The firm has a market cap of $6.48 billion, a price-to-earnings ratio of 10.17, a PEG ratio of 4.79 and a beta of 1.40.

Perrigo (NYSE:PRGO) last announced its earnings results on Thursday, August 8th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.05. Perrigo had a net margin of 1.87% and a return on equity of 9.57%. The company had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.13 billion. During the same period in the previous year, the business earned $1.22 EPS. The company’s revenue was down 3.2% on a year-over-year basis. Research analysts predict that Perrigo Company PLC will post 3.95 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 17th. Stockholders of record on Friday, August 30th will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date is Thursday, August 29th. Perrigo’s dividend payout ratio (DPR) is presently 18.46%.

PRGO has been the topic of several recent analyst reports. SunTrust Banks boosted their target price on shares of Perrigo to $51.00 and gave the company a “hold” rating in a research note on Monday, May 20th. ValuEngine raised shares of Perrigo from a “strong sell” rating to a “sell” rating in a research note on Thursday, August 1st. Cantor Fitzgerald cut their target price on shares of Perrigo from $107.00 to $60.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 12th. Finally, Wells Fargo & Co reissued a “hold” rating on shares of Perrigo in a research note on Tuesday, July 2nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $55.14.

Several hedge funds and other institutional investors have recently bought and sold shares of PRGO. Geode Capital Management LLC lifted its holdings in Perrigo by 12.4% in the fourth quarter. Geode Capital Management LLC now owns 1,687,709 shares of the company’s stock valued at $65,286,000 after acquiring an additional 186,095 shares during the period. Nisa Investment Advisors LLC increased its position in shares of Perrigo by 26.9% in the first quarter. Nisa Investment Advisors LLC now owns 38,885 shares of the company’s stock valued at $1,873,000 after buying an additional 8,244 shares in the last quarter. Oakbrook Investments LLC purchased a new stake in shares of Perrigo in the first quarter valued at approximately $304,000. Investors Research Corp purchased a new stake in shares of Perrigo in the first quarter valued at approximately $118,000. Finally, Brinker Capital Inc. increased its position in shares of Perrigo by 758.1% in the first quarter. Brinker Capital Inc. now owns 47,512 shares of the company’s stock valued at $2,288,000 after buying an additional 41,975 shares in the last quarter. 88.22% of the stock is currently owned by institutional investors and hedge funds.

About Perrigo

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.

Featured Article: Coverage Ratio

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.